2m 2m 2m 2m 2m 2m 2m
XERIS BIPH HLDG (XERS)
NASDAQ
$7.50+$0.05 (+0.67%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.4BMarket Cap
- -0.53%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
XERIS BIPH HLDG (XERS)
$7.50+$0.05 (+0.67%)
XERS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.45 | ||
Change | -$0.22 (-2.87%) | ||
Open | $7.89 | ||
High | $7.89 | ||
Low | $7.40 | ||
Previous Close | $7.67 | ||
Volume | 3,208,553 | ||
30-Day Average Volume | 1,631,535 | ||
1-Week Change | -12.66% | ||
1-Month Change | -11.20% | ||
1-Year Change | -0.53% | ||
3-Year Change | 254.76% | ||
5-Year Change | 179.03% | ||
Fundamentals | |||
Shares Outstanding | 182.3M | ||
Total Assets | $411.9M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $91.0M | ||
Net Income | -$31.1M | ||
Free Cash Flow | $8.5M | ||
EBIT | -$31.1M | ||
EBITDA | -$28.4M | ||
Net Working Capital | $85.2M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -52 | ||
Enterprise Value/Revenue | 16 | ||
P/B | -140 | ||
P/E | -41 | ||
PEG | 0 | ||
Price/Free Cash Flow | 160 | ||
Price/Operating Cash Flow | 164 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue